Key statistics
As of last trade Supernus Pharmaceuticals Inc (SUPN:NMQ) traded at 54.88, -8.04% below its 52-week high of 59.68, set on Feb 25, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 53.99 |
|---|---|
| High | 54.98 |
| Low | 52.95 |
| Bid | 54.76 |
| Offer | 54.91 |
| Previous close | 55.09 |
| Average volume | 1.14m |
|---|---|
| Shares outstanding | 57.46m |
| Free float | 54.79m |
| P/E (TTM) | -- |
| Market cap | 3.17bn USD |
| EPS (TTM) | -0.6839 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 18:23 GMT.
More ▼
- Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
- Supernus Pharmaceuticals to Participate in March Investor Conferences
- Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
- Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
- Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
- Supernus Announces Third Quarter 2025 Financial Results
- Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
- Supernus Pharmaceuticals to Participate in September Investor Conferences
- Supernus Announces Second Quarter 2025 Financial Results
More ▼
